Study funded by Sanofi

Download Poster (499.69 KB)

Publication
  • ISTH •
  • 14 July, 2026 •
  • •

Joint Health Outcomes With Efanesoctocog Alfa Prophylaxis for Patients With Severe Hemophilia A: Third Interim Analysis of the Phase 3 XTEND-ed Study

Christoph Königs, Annette von Drygalski, Cedric Hermans, Barbara A. Konkle, María Teresa Álvarez Román, Liane Khoo, Nobuaki Suzuki, Graham Neill, Linda Bystrická, Meredith Foster, Elena Santagostino, Sriya Gunawardena, Robert Klamroth

Available materials

Poster
Publication
  • ISTH •
  • 14 July, 2026 •
  • •

Perioperative management of Haemophilia B: A HaemSTAR UK-wide audit

Jayna Mistry, Sarah Idris, Thomas Flamini, Srdan Rogosic, Bradley Dixon, Rosemary Barker, Elizabeth Ryan, Abigail Wright, Asiya Nur, Kate Burley, Yen Yeo, Samuel Harvey, Arpan Doshi, HaemSTAR Collaborators, Philip Nicolson, Jaspal Dhir, Charles Hay, Gillian Lowe, Richard Buka

Available materials

Poster
Publication
  • ISTH •
  • 14 July, 2026 •
  • •

Baseline Characteristics of Patients Switching to Prophylactic Efanesoctocog Alfa Therapy Evaluated for Joint Health in Hemophilia A in Taiwan (PROTECT-ALT Study)

Yeu-Chin Chen, Ming-Ching Shen, Cheng-Wei Huang, Hung Chang, Jiaan-Der Wang, Sheng-Chieh Chou, Ching-Tien Peng, Chih-Cheng Hsiao, Chia-Yau Chang, Te-Fu Weng, Tong-Ling Chien, Ching-Min Chang, Shyh-Shin Chiou

Available materials

Poster
Publication
  • ISTH •
  • 14 July, 2026 •
  • •

Interim analysis of the A-MORE real-world study: 4-year treatment outcomes with a recombinant factor VIII Fc in the overall and non-severe populations

Jan Astermark, Antonio Coppola, Swee Wenning, Ruben Berrueco, Ester Zapotocka, Andreu Schoenenberger López, Eva Bednar, Stefan Lethagen

Available materials

Poster
Publication
  • WFH •
  • 20 April, 2026 •
  • •

Joint Health Outcomes with Efanesoctocog Alfa in Adults/Adolescents from XTEND-1 Continuing in XTEND-ed: Plain Language Summary

Christoph Königs, Annette von Drygalski, Cedric Hermans, Barbara A. Konkle, Paul Van der Valk, Liane Khoo, Nobuaki Suzuki, Liqi Feng, Umer Khan, Linda Bystrická, Jennifer Dumont, Elena Santagostino, Lara Mamikonian, Robert Klamroth

Available materials

Oral Presentation
Publication
  • WFH •
  • 20 April, 2026 •
  • •

Physical Activity and Bleed Prevention for People With Severe Haemophilia A Treated With Once-Weekly Efanesoctocog Alfa: A Plain-Language Summary of 12-Month Interim Results From the FREEDOM Study

Ana Boban, Kate Talks, Irena Preložnik Zupan, Paul Van der Valk, Josefin Blomkvist, Elena Santagostino, Markus Fusser, Jan Astermark

Available materials

Poster
Publication
  • EAHAD •
  • 6 February, 2026 •
  • •

Efanesoctocog Alfa Prophylaxis for People with Severe Haemophilia A: Third Interim Results from the XTEND-ed Long-Term Extension Study

Sophie Susen, Anthony KC Chan, Pratima Chowdary, Stephanie P’ng, Manuela Albisetti, Keiji Nogami, Karin Fijnvandraat, Jennifer Dumont , Elena Santagostino, Sriya Gunawardena, Mahnouch Georget, Lynn Malec

Available materials

Oral Presentation
Publication
  • EAHAD •
  • 4 February, 2026 •
  • •

Physical Activity and Efficacy in Patients with Severe Haemophilia A Treated with Efanesoctocog Alfa: 12-Month Interim Results from FREEDOM

Jan Astermark, Olga Benitez Hidalgo, Hervé Chambost, Antonio Coppola, Shamil Sadikhov, Jenny Björkqvist, Markus Fusser, Niamh O’Connell

Available materials

Poster
Sign up for alerts